Intuitive Surgical opened higher at $453.60, compared with its previous close of $448.76. In the last trading session, the stock traded between $437.89 and $453.60. It showed a downward intraday trend.
return calculator
Time Period
An investment of $100 made 5 years ago in Intuitive Surgical is now worth
$ 121.38
giving a profit of
$ 21.38 (21.38%)
invest with $1
Note: Past profits do not guarantee future returns.
Analyst Overview
Rating from 20 Analysts
Buy
90%
Hold
10%
Sell
0%
Markets Today
Today's Change
$-10.43 (-2.32%)
Day High
$453.60
Day Low
$437.89
Day Open
$453.60
Prev Close
$448.76
Volume
9,08,767
1W Return
-1.22%
1M Return
6.35%
3M Return
24.12%
6M Return
-3.42%
1Y Return
-18.46%
Fundamentals
Market Cap ($ Mn)
1,51,944
PE Ratio
42.73
PB Ratio
7.26
PEG Ratio
2.99
ROE
16.70%
ROCE
16.52%
EPS (TTM)
$1.48
Investment Returns
1 Week
-1.22%
1 Month
6.35%
3 Months
24.12%
6 Months
-3.42%
9 Months
-13.64%
Financials
Quarterly
All values in $ Mn
2.4K
Jun 25
2.5K
Sep 25
2.9K
Dec 25
2.8K
Mar 26
2.9K
Jun 26
3.0K
Sep 26
Updates
21Oct
Evercore ISI lowers Intuitive Surgical price target to $385
Evercore ISI Group lowered Intuitive Surgical's price target from $400 to $385. The firm maintained an In-Line rating on the stock. Analyst Vijay Kumar authored the rating action.
9 days ago
21Oct
Baird maintains Outperform on Intuitive Surgical, lifts target to $550
Baird analyst David Rescott maintains an Outperform rating on Intuitive Surgical. Price target increased from $513 to $550. The new target represents a $37 increase over the prior level.
9 days ago
21Oct
BTIG reiterates Buy on Intuitive Surgical with $454 price target
BTIG analyst Ryan Zimmerman reiterated a Buy rating on Intuitive Surgical. The $454 price target remains unchanged. The action reflects continued confidence in the company's outlook.
9 days ago
21Oct
Intuitive Surgical Q3FY26 Results: Revenue up 22%, EPS beats estimates
Adjusted EPS of $3.00 beat consensus by 13.64%, up 25% YoY. Revenue rose 22% YoY to $3.05 billion, exceeding estimates. GAAP net income fell 25.7% YoY due to a $450 million litigation settlement. Management guided for 3-5% reduction in I&A revenue per procedure starting 2027. Full-year procedure growth guidance narrowed to 14-15%.
9 days ago
21Oct
Intuitive Surgical notes 2026 growth outlook factors in US, China risks
Intuitive Surgical forecasts 14-15% worldwide da Vinci procedure growth for 2026. Non-GAAP gross profit margin guided at 68.7% to 69.3%, including 0.9% tariff impact. Growth outlook accounts for ACA premium subsidy changes affecting US patient behavior. Forecast also factors in competitive intensity and tender volumes in China.
9 days ago
30Sep
Intuitive Surgical model suggests specialized robots beat humanoids
RoboStrategy CEO Andrew Kang argues specialized robotics can create trillion-dollar companies. Intuitive Surgical generated $10.1 billion revenue in 2025, up 21% YoY. Tesla's Optimus aims for general-purpose tasks, facing higher technological hurdles. Intuitive Surgical's market cap stood at roughly $145 billion as of September 29.
